United Kingdom Liquid Biopsy Market By Offering (Testing Service, Kits, Platform, Other consumables), By Technology (Polymerase Chain Reactions (PCR), Next Generation Sequencing (NGS), Others), By Workflow (Sample Preparation, Library Preparation, Sequencing, Data Analysis & Management), By Sample (Blood, Urine, Saliva, Others), By Circulating Biomarkers (Circulating Tumor Cells (CTCs), Cell-free
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationUnited Kingdom Liquid Biopsy Market By Offering (Testing Service, Kits, Platform, Other consumables), By Technology (Polymerase Chain Reactions (PCR), Next Generation Sequencing (NGS), Others), By Workflow (Sample Preparation, Library Preparation, Sequencing, Data Analysis & Management), By Sample (Blood, Urine, Saliva, Others), By Circulating Biomarkers (Circulating Tumor Cells (CTCs), Cell-free
The United Kingdom Liquid Biopsy Market is anticipated to grow at a significant rate in the projected period of 2024-2028. Liquid biopsy has emerged as a groundbreaking diagnostic tool in the field of oncology, enabling non-invasive detection and monitoring of various types of cancer. The United Kingdom has been at the forefront of embracing this innovative technology, revolutionizing cancer detection and treatment strategies.
Cancer remains a significant healthcare challenge in the United Kingdom, with an increasing incidence and mortality rate. Conventional tissue biopsies, while effective, are invasive, time-consuming, and often provide limited information due to tumor heterogeneity. Liquid biopsy offers a promising alternative, allowing the detection and monitoring of cancer through the analysis of circulating tumor DNA (ctDNA), circulating tumor cells (CTCs), and other biomarkers present in blood or other bodily fluids.
With a few uses already approved by the U.S. Food and Drug Administration (FDA), liquid biopsy is a relatively new test with a number of potentially groundbreaking applications in the treatment of cancer. Its advantages are still being studied. Because of its potential to assist healthcare professionals in diagnosing and monitoring cancer with a straightforward blood test, liquid biopsy tests are an active area of research and development. Liquid biopsy tests are currently being developed to do things that traditional biopsy techniques cannot, such as detecting cancer before a tumor has formed. Even so, more investigation is required to comprehend the potential applications of liquid biopsy. In specific circumstances, they can assist in the diagnosis of certain cancers and guide treatment choices. They might have a lot more applications in the future, leading to the growth of the United Kingdom Liquid Biopsy Market.
According to Cancer Research UK, lung cancer affects about 46,700 people annually in the United Kingdom alone. Sadly, only 1 in 20 people will live for 10 years or more, and this number has not decreased over the past ten years.
Moreover, collaborations between academic institutions, healthcare providers, and industry players are fostering innovation and driving the adoption of liquid biopsy across the United Kingdom. The National Health Service (NHS) plays a vital role in facilitating the integration of liquid biopsy into routine clinical practice, ensuring equitable access and improved patient outcomes, thus augmenting the growth of the United Kingdom Liquid Biopsy Market.
High Efficiency of Liquid Biopsy spur its demand in United Kingdom
As per the Research Cancer Research Fund, in 2019, 3,87,820 cases of cancer were diagnosed in United Kingdom
Growing Demand for Polymerase Chain Reaction (PCR) Technology drives United Kingdom Liquid Biopsy Market
As per Office for National Statistics, in 2021, compared to 10.0% in 2020, the total current healthcare expenditure increased in real terms by 7.1% after accounting for the effects of inflation on the economy as a whole.
Recent Developments
- In 2020, According to a news release from the NIH National CancerInstitute, the US Food and Drug Administration (FDA) expanded its clearance fortwo liquid biopsy tests in United Kingdom—Guardant Health's Guardant360 CDx andFoundation Medicine's FoundationOne Liquid CDx—for use as companion diagnostictests and for general tumor profiling for specific non-small cell lung,prostate, breast, and ovarian cancers.
Mergers and Acquisitions
Market Segmentation
United Kingdom Liquid Biopsy Market is segmented into Offering, Technology, Workflow,
Company Profiles
F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc, PerkinElmer Inc., Illumina, Inc., QIAGEN NV, Dxcover Limited, Abcodia Ltd, Sysmex Corporation, Bio-Rad Laboratories, Inc are some of the key players in the United Kingdom Liquid Biopsy Market.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023-2028 |
| Report coverage | Revenue forecast, company shares, competitive landscape, growth factors, and trends |
| Segments covered | Offering Technology Workflow Sample Circulating Biomarker Application End User Region |
| Country scope | Scotland, South-East, London, South-West, East-Anglia, Yorkshire & Humberside, and East Midlands |
| Key companies profiled | F. Hoffmann-La Roche AG, Thermo Fisher Scientific, Inc, PerkinElmer Inc., Illumina, Inc., QIAGEN NV, Dxcover Limited, Abcodia Ltd, Sysmex Corporation, Bio-Rad Laboratories, Inc |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy